source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[biological replicate]	characteristics[sampling time]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[instrument]	comment[modification parameter]	comment[modification parameter]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD009219-Sample-1	Homo sapiens	blood plasma	839	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	1	no aplicable	839-1	proteomic profiling by mass spectrometry	839-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/839-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	30 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-1	Homo sapiens	blood plasma	839	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	1	no aplicable	839-2	proteomic profiling by mass spectrometry	839-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/839-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	31 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-1	Homo sapiens	blood plasma	839	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	1	no aplicable	839-3	proteomic profiling by mass spectrometry	839-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/839-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	32 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-1	Homo sapiens	blood plasma	839	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	1	no aplicable	839-4	proteomic profiling by mass spectrometry	839-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/839-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	33 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-1	Homo sapiens	blood plasma	839	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	1	no aplicable	839-5	proteomic profiling by mass spectrometry	839-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/839-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	34 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-2	Homo sapiens	blood plasma	901	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	2	no aplicable	901-1	proteomic profiling by mass spectrometry	901-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/901-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	35 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-2	Homo sapiens	blood plasma	901	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	2	no aplicable	901-2	proteomic profiling by mass spectrometry	901-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/901-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	36 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-2	Homo sapiens	blood plasma	901	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	2	no aplicable	901-3	proteomic profiling by mass spectrometry	901-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/901-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	37 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-2	Homo sapiens	blood plasma	901	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	2	no aplicable	901-4	proteomic profiling by mass spectrometry	901-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/901-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	38 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-2	Homo sapiens	blood plasma	901	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	2	no aplicable	901-5	proteomic profiling by mass spectrometry	901-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/901-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	39 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-3	Homo sapiens	blood plasma	905	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	3	no aplicable	905-1	proteomic profiling by mass spectrometry	905-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/905-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	40 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-3	Homo sapiens	blood plasma	905	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	3	no aplicable	905-2	proteomic profiling by mass spectrometry	905-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/905-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	41 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-3	Homo sapiens	blood plasma	905	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	3	no aplicable	905-3	proteomic profiling by mass spectrometry	905-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/905-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	42 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-3	Homo sapiens	blood plasma	905	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	3	no aplicable	905-4	proteomic profiling by mass spectrometry	905-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/905-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	43 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-3	Homo sapiens	blood plasma	905	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	3	no aplicable	905-5	proteomic profiling by mass spectrometry	905-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/905-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	44 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-4	Homo sapiens	blood plasma	908	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	4	no aplicable	908-1	proteomic profiling by mass spectrometry	908-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/908-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	46 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-4	Homo sapiens	blood plasma	908	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	4	no aplicable	908-2	proteomic profiling by mass spectrometry	908-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/908-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	47 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-4	Homo sapiens	blood plasma	908	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	4	no aplicable	908-4	proteomic profiling by mass spectrometry	908-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/908-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	49 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-4	Homo sapiens	blood plasma	908	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	4	no aplicable	908-5	proteomic profiling by mass spectrometry	908-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/908-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	50 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-4	Homo sapiens	blood plasma	908	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	4	no aplicable	908-6	proteomic profiling by mass spectrometry	908-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/908-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	51 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-5	Homo sapiens	blood plasma	910	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	5	no aplicable	910-3	proteomic profiling by mass spectrometry	910-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/910-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	54 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-5	Homo sapiens	blood plasma	910	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	5	no aplicable	910-4	proteomic profiling by mass spectrometry	910-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/910-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	55 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-5	Homo sapiens	blood plasma	910	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	5	no aplicable	910-5	proteomic profiling by mass spectrometry	910-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/910-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	56 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-6	Homo sapiens	blood plasma	911	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	6	no aplicable	911-3	proteomic profiling by mass spectrometry	911-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/911-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	59 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-6	Homo sapiens	blood plasma	911	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	6	no aplicable	911-4	proteomic profiling by mass spectrometry	911-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/911-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	60 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-6	Homo sapiens	blood plasma	911	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	6	no aplicable	911-5	proteomic profiling by mass spectrometry	911-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/911-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	61 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-7	Homo sapiens	blood plasma	818	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	7	no aplicable	818-3	proteomic profiling by mass spectrometry	818-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/818-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	64 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-7	Homo sapiens	blood plasma	818	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	7	no aplicable	818-4	proteomic profiling by mass spectrometry	818-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/818-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	65 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-7	Homo sapiens	blood plasma	818	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	7	no aplicable	818-5	proteomic profiling by mass spectrometry	818-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/818-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	66 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-7	Homo sapiens	blood plasma	818	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	7	no aplicable	818-6	proteomic profiling by mass spectrometry	818-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/818-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	67 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-8	Homo sapiens	blood plasma	838	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	8	no aplicable	838-3	proteomic profiling by mass spectrometry	838-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/838-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	70 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-8	Homo sapiens	blood plasma	838	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	8	no aplicable	838-4	proteomic profiling by mass spectrometry	838-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/838-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	71 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-8	Homo sapiens	blood plasma	838	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	8	no aplicable	838-5	proteomic profiling by mass spectrometry	838-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/838-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	72 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-8	Homo sapiens	blood plasma	838	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	8	no aplicable	838-6	proteomic profiling by mass spectrometry	838-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/838-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	73 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-9	Homo sapiens	blood plasma	843	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	9	no aplicable	843-3	proteomic profiling by mass spectrometry	843-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/843-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	76 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-9	Homo sapiens	blood plasma	843	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	9	no aplicable	843-4	proteomic profiling by mass spectrometry	843-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/843-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	77 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-9	Homo sapiens	blood plasma	843	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	9	no aplicable	843-5	proteomic profiling by mass spectrometry	843-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/843-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	78 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-9	Homo sapiens	blood plasma	843	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	9	no aplicable	843-6	proteomic profiling by mass spectrometry	843-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/843-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	79 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-10	Homo sapiens	blood plasma	849	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	10	no aplicable	849-3	proteomic profiling by mass spectrometry	849-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/849-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	82 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-10	Homo sapiens	blood plasma	849	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	10	no aplicable	849-4	proteomic profiling by mass spectrometry	849-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/849-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	83 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-10	Homo sapiens	blood plasma	849	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	10	no aplicable	849-5	proteomic profiling by mass spectrometry	849-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/849-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	84 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-11	Homo sapiens	blood plasma	856	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	11	no aplicable	856-3	proteomic profiling by mass spectrometry	856-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/856-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	87 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-11	Homo sapiens	blood plasma	856	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	11	no aplicable	856-4	proteomic profiling by mass spectrometry	856-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/856-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	88 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-11	Homo sapiens	blood plasma	856	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	11	no aplicable	856-5	proteomic profiling by mass spectrometry	856-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/856-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	89 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-11	Homo sapiens	blood plasma	856	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	11	no aplicable	856-6	proteomic profiling by mass spectrometry	856-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/856-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	90 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-12	Homo sapiens	blood plasma	887	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	12	no aplicable	887-3	proteomic profiling by mass spectrometry	887-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/887-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	93 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-12	Homo sapiens	blood plasma	887	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	12	no aplicable	887-4	proteomic profiling by mass spectrometry	887-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/887-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	94 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-12	Homo sapiens	blood plasma	887	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	12	no aplicable	887-5	proteomic profiling by mass spectrometry	887-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/887-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	95 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-13	Homo sapiens	blood plasma	888	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	13	no aplicable	888-4	proteomic profiling by mass spectrometry	888-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/888-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	99 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-13	Homo sapiens	blood plasma	888	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	13	no aplicable	888-5	proteomic profiling by mass spectrometry	888-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/888-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	100 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-13	Homo sapiens	blood plasma	888	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	13	no aplicable	888-6	proteomic profiling by mass spectrometry	888-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/888-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	101 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-14	Homo sapiens	blood plasma	897	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	14	no aplicable	897-4	proteomic profiling by mass spectrometry	897-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/897-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	105 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-14	Homo sapiens	blood plasma	897	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	14	no aplicable	897-5	proteomic profiling by mass spectrometry	897-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/897-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	106 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-15	Homo sapiens	blood plasma	898	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	15	no aplicable	898-3	proteomic profiling by mass spectrometry	898-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/898-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	110 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-15	Homo sapiens	blood plasma	898	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	15	no aplicable	898-4	proteomic profiling by mass spectrometry	898-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/898-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	111 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-15	Homo sapiens	blood plasma	898	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	15	no aplicable	898-5	proteomic profiling by mass spectrometry	898-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/898-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	112 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-15	Homo sapiens	blood plasma	898	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	15	no aplicable	898-6	proteomic profiling by mass spectrometry	898-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/898-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	113 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-16	Homo sapiens	blood plasma	900	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	16	no aplicable	900-3	proteomic profiling by mass spectrometry	900-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/900-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	116 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-16	Homo sapiens	blood plasma	900	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	16	no aplicable	900-4	proteomic profiling by mass spectrometry	900-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/900-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	117 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-16	Homo sapiens	blood plasma	900	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	16	no aplicable	900-5	proteomic profiling by mass spectrometry	900-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/900-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	118 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-16	Homo sapiens	blood plasma	900	not applicable	not applicable	not applicable	not applicable	not applicable	Schizophrenia	depleted	16	no aplicable	900-6	proteomic profiling by mass spectrometry	900-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/900-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	119 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-17	Homo sapiens	blood plasma	1108	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	17	no aplicable	1108-3	proteomic profiling by mass spectrometry	1108-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1108-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	122 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-17	Homo sapiens	blood plasma	1108	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	17	no aplicable	1108-4	proteomic profiling by mass spectrometry	1108-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1108-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	123 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-17	Homo sapiens	blood plasma	1108	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	17	no aplicable	1108-5	proteomic profiling by mass spectrometry	1108-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1108-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	124 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-17	Homo sapiens	blood plasma	1108	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	17	no aplicable	1108-6	proteomic profiling by mass spectrometry	1108-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1108-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	125 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-18	Homo sapiens	blood plasma	1109	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	18	no aplicable	1109-3	proteomic profiling by mass spectrometry	1109-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1109-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	128 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-18	Homo sapiens	blood plasma	1109	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	18	no aplicable	1109-4	proteomic profiling by mass spectrometry	1109-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1109-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	129 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-18	Homo sapiens	blood plasma	1109	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	18	no aplicable	1109-5	proteomic profiling by mass spectrometry	11095-.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/11095-.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	130 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-18	Homo sapiens	blood plasma	1109	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	18	no aplicable	1109-6	proteomic profiling by mass spectrometry	1109-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1109-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	131 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-19	Homo sapiens	blood plasma	1113	not applicable	not applicable	not applicable	not applicable	not applicable	#N/D	depleted	19	no aplicable	1113-1	proteomic profiling by mass spectrometry	1113-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1113-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	132 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-19	Homo sapiens	blood plasma	1113	not applicable	not applicable	not applicable	not applicable	not applicable	#N/D	depleted	19	no aplicable	1113-2	proteomic profiling by mass spectrometry	1113-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1113-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	133 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-19	Homo sapiens	blood plasma	1113	not applicable	not applicable	not applicable	not applicable	not applicable	#N/D	depleted	19	no aplicable	1113-3	proteomic profiling by mass spectrometry	1113-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1113-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	134 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-19	Homo sapiens	blood plasma	1113	not applicable	not applicable	not applicable	not applicable	not applicable	#N/D	depleted	19	no aplicable	1113-4	proteomic profiling by mass spectrometry	1113-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1113-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	135 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-19	Homo sapiens	blood plasma	1113	not applicable	not applicable	not applicable	not applicable	not applicable	#N/D	depleted	19	no aplicable	1113-5	proteomic profiling by mass spectrometry	1113-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1113-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	136 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-20	Homo sapiens	blood plasma	118	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	20	no aplicable	1118-3	proteomic profiling by mass spectrometry	118-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/118-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	140 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-20	Homo sapiens	blood plasma	1118	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	20	no aplicable	1118-4	proteomic profiling by mass spectrometry	1118-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1118-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	141 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-20	Homo sapiens	blood plasma	1118	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	20	no aplicable	1118-5	proteomic profiling by mass spectrometry	1118-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1118-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	142 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-20	Homo sapiens	blood plasma	1118	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	20	no aplicable	1118-6	proteomic profiling by mass spectrometry	1118-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1118-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	143 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-21	Homo sapiens	blood plasma	1134	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	21	no aplicable	1134-1	proteomic profiling by mass spectrometry	1134-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1134-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	144 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-21	Homo sapiens	blood plasma	1134	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	21	no aplicable	1134-2	proteomic profiling by mass spectrometry	1134-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1134-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	145 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-21	Homo sapiens	blood plasma	1134	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	21	no aplicable	1134-3	proteomic profiling by mass spectrometry	1134-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1134-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	146 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-21	Homo sapiens	blood plasma	1134	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	21	no aplicable	1134-4	proteomic profiling by mass spectrometry	1134-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1134-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	147 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-21	Homo sapiens	blood plasma	1134	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	21	no aplicable	1134-5	proteomic profiling by mass spectrometry	1134-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1134-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	148 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-21	Homo sapiens	blood plasma	1134	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	21	no aplicable	1134-6	proteomic profiling by mass spectrometry	1134-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1134-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	149 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-22	Homo sapiens	blood plasma	1135	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	22	no aplicable	1135-3	proteomic profiling by mass spectrometry	1135-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1135-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	152 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-22	Homo sapiens	blood plasma	1135	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	22	no aplicable	1135-4	proteomic profiling by mass spectrometry	1135-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1135-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	153 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-22	Homo sapiens	blood plasma	1135	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	22	no aplicable	1135-5	proteomic profiling by mass spectrometry	1135-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1135-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	154 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-22	Homo sapiens	blood plasma	1135	not applicable	not applicable	not applicable	not applicable	not applicable	normal	depleted	22	no aplicable	1135-6	proteomic profiling by mass spectrometry	1135-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1135-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	155 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-23	Homo sapiens	blood plasma	1251	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	23	no aplicable	1251-1	proteomic profiling by mass spectrometry	1251-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1251-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	156 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-23	Homo sapiens	blood plasma	1251	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	23	no aplicable	1251-2	proteomic profiling by mass spectrometry	1251-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1251-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	157 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-23	Homo sapiens	blood plasma	1251	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	23	no aplicable	1251-3	proteomic profiling by mass spectrometry	1251-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1251-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	158 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-23	Homo sapiens	blood plasma	1251	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	23	no aplicable	1251-4	proteomic profiling by mass spectrometry	1251-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1251-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	159 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-23	Homo sapiens	blood plasma	1251	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	23	no aplicable	1251-5	proteomic profiling by mass spectrometry	1251-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1251-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	160 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-24	Homo sapiens	blood plasma	1260	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	24	no aplicable	1260-1	proteomic profiling by mass spectrometry	1260-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1260-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	162 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-24	Homo sapiens	blood plasma	1260	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	24	no aplicable	1260-2	proteomic profiling by mass spectrometry	1260-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1260-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	163 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-24	Homo sapiens	blood plasma	1260	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	24	no aplicable	1260-4	proteomic profiling by mass spectrometry	1260-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1260-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	165 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-24	Homo sapiens	blood plasma	1260	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	24	no aplicable	1260-5	proteomic profiling by mass spectrometry	1260-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1260-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	166 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-24	Homo sapiens	blood plasma	1260	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	24	no aplicable	1260-6	proteomic profiling by mass spectrometry	1260-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1260-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	167 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-25	Homo sapiens	blood plasma	1313	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	25	no aplicable	1313-1	proteomic profiling by mass spectrometry	1313-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1313-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	168 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-25	Homo sapiens	blood plasma	1313	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	25	no aplicable	1313-2	proteomic profiling by mass spectrometry	1313-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1313-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	169 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-25	Homo sapiens	blood plasma	1313	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	25	no aplicable	1313-3	proteomic profiling by mass spectrometry	1313-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1313-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	170 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-25	Homo sapiens	blood plasma	1313	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	25	no aplicable	1313-4	proteomic profiling by mass spectrometry	1313-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1313-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	171 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-25	Homo sapiens	blood plasma	1313	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	25	no aplicable	1313-5	proteomic profiling by mass spectrometry	1313-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1313-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	172 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-26	Homo sapiens	blood plasma	1348	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	26	no aplicable	1348-1	proteomic profiling by mass spectrometry	1348-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1348-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	174 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-26	Homo sapiens	blood plasma	1348	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	26	no aplicable	1348-2	proteomic profiling by mass spectrometry	1348-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1348-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	175 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-26	Homo sapiens	blood plasma	1348	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	26	no aplicable	1348-3	proteomic profiling by mass spectrometry	1348-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1348-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	176 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-26	Homo sapiens	blood plasma	1348	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	26	no aplicable	1348-4	proteomic profiling by mass spectrometry	1348-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1348-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	177 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-26	Homo sapiens	blood plasma	1348	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	26	no aplicable	1348-5	proteomic profiling by mass spectrometry	1348-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1348-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	178 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-27	Homo sapiens	blood plasma	1400	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	27	no aplicable	1400-1	proteomic profiling by mass spectrometry	1400-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1400-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	180 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-27	Homo sapiens	blood plasma	1400	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	27	no aplicable	1400-2	proteomic profiling by mass spectrometry	1400-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1400-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	181 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-27	Homo sapiens	blood plasma	1400	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	27	no aplicable	1400-3	proteomic profiling by mass spectrometry	1400-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1400-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	182 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-27	Homo sapiens	blood plasma	1400	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	27	no aplicable	1400-4	proteomic profiling by mass spectrometry	1400-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1400-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	183 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-27	Homo sapiens	blood plasma	1400	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	27	no aplicable	1400-5	proteomic profiling by mass spectrometry	1400-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1400-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	184 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-28	Homo sapiens	blood plasma	1412	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	28	no aplicable	1412-3	proteomic profiling by mass spectrometry	1412-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1412-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	188 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-28	Homo sapiens	blood plasma	1412	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	28	no aplicable	1412-4	proteomic profiling by mass spectrometry	1412-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1412-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	189 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-28	Homo sapiens	blood plasma	1412	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	28	no aplicable	1412-5	proteomic profiling by mass spectrometry	1412-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1412-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	190 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-28	Homo sapiens	blood plasma	1412	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	28	no aplicable	1412-6	proteomic profiling by mass spectrometry	1412-6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1412-6.raw	6	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	191 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-29	Homo sapiens	blood plasma	1550	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	29	no aplicable	1550-1	proteomic profiling by mass spectrometry	1550-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1550-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	192 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-29	Homo sapiens	blood plasma	1550	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	29	no aplicable	1550-2	proteomic profiling by mass spectrometry	1550-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1550-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	193 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-29	Homo sapiens	blood plasma	1550	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	29	no aplicable	1550-3	proteomic profiling by mass spectrometry	1550-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1550-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	194 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-29	Homo sapiens	blood plasma	1550	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	29	no aplicable	1550-4	proteomic profiling by mass spectrometry	1550-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1550-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	195 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-29	Homo sapiens	blood plasma	1550	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	29	no aplicable	1550-5	proteomic profiling by mass spectrometry	1550-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1550-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	196 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-30	Homo sapiens	blood plasma	1689	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	30	no aplicable	1689-1	proteomic profiling by mass spectrometry	1689-1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1689-1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	198 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-30	Homo sapiens	blood plasma	1689	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	30	no aplicable	1689-2	proteomic profiling by mass spectrometry	1689-2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1689-2.raw	2	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	199 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-30	Homo sapiens	blood plasma	1689	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	30	no aplicable	1689-3	proteomic profiling by mass spectrometry	1689-3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1689-3.raw	3	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	200 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-30	Homo sapiens	blood plasma	1689	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	30	no aplicable	1689-4	proteomic profiling by mass spectrometry	1689-4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1689-4.raw	4	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	201 NCE	1.2 Da	0.6 Da	blood plasma
PXD009219-Sample-30	Homo sapiens	blood plasma	1689	not applicable	not applicable	not applicable	not applicable	not applicable	Bipolar Disorder	depleted	30	no aplicable	1689-5	proteomic profiling by mass spectrometry	1689-5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD009219/1689-5.raw	5	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1001742; NT=LTQ Orbitrap Velos	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	AC=MS:1000422;NT=HCD	202 NCE	1.2 Da	0.6 Da	blood plasma